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Abstract 
The purpose of this study was to determine the prevalence of liver disorders through liver function enzyme tests (LFTs) in 
Islamabad. A total of 250 blood samples were screened in Kahuta Research Laboratory (KRL), Islamabad for the presence of liver 
disorders through liver function enzyme tests (LFTs) viz., alanine aminotransferase (ALT), Total Bilirubin (T.Bil) and alkaline 
phosphatase (ALP). The results were analyzed by comparing the correlation among ALT, ALP and T. Bilirubin and compiled by 
comparing elevated level of LF enzymes with respect to age. It has been observed that correlation coefficient between ALT and T. 
Bilirubin; ALP and T. Bilirubin; ALT and ALP was positive values which indicate that slightly elevation in these enzymes released 
from hepatocytes cause liver disorders. The level of ALT and ALP abruptly decreased in (1-15 years), and then it gradually 
increased in age groups 16-30 years, 31-45 years. Their level was much higher in (46-60 years). However the level of T. Bilirubin 
was higher in children and adults in age groups (1-15years) and (46-60 years) but it was slightly elevated in age groups (16-30 
years) and (31-45 years). It is concluded that elevation of liver enzymes is responsible for liver disorders. 
Keywords: Liver function test, Liver disorders in Islamabad region of Pakistan. 
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INTRODUCTION 
Liver performs its vital functions such as synthesis, 
storage, recycling and detoxification under normal 
conditions. There are number of factors involved in the 
elevation of liver enzymes. Previous studies reported risk 
factors included parental drug abuse (Marengo, 1993), blood 
transfusion (Dusheiko, 1990), accidental needle stick 
(Kiyosawa et al., 1991), ear piercing, bite by human 
(Abildgaard and Petrsland, 1991), haematophagous 
arthropods such as mosquito, ticks and bedbugs (Hollinger, 
1990), organ recipients (Pereia et al., 1991), obesity (fatty 
deposits in liver cells) (Fattovich et al., 1997). Urine, saliva 
and blood samples used to detect sick factor of liver disorder 
(Dubios et al., 1994). Liver disorders including Hepatitis A, B, 
C, D, E and G, liver tumors, liver stones, liver cancer and 
obstructions of bile duct due to stones (Stanley, 1996).  
It has been observed that liver diseases also induced by 
antibiotics such as Nitrofuranation, Amoxicillin, Clavulanic 
acid, Tetracycline, Isoniazid and Methotrexate used to treat 
autoimmune disorders and cancer. Disulfiram used to treat 
alcoholics can also cause liver inflammation (Seng and 
Katzel, 2001). Numerous medications cause liver 
inflammation including taking excess amount of 
Acetaminophen (Schalm et al., 1997). Niacin is used to 
control elevated blood level of cholesterol, but liver 
inflammation for this medication is related to the dose taken 
(Prince et al., 2002). 
Liver function enzyme tests (LFTs) including Alanine 
transaminase (ALT), Aspartate transaminase (AST), Alkaline 
phosphatase (ALP), Albumin, Total bilirubin (T.BIL), Direct 
bilirubin and Gamma glutamyl transpeptidase (GGT) tests 
are used as a marker to determine the status of patient
’
s liver 
(Haurigan and Bowling, 2001). Medical treatments for liver 
disorder include surgery, low sodium diet and water pills 
(diuretics), anti-inflammatory drugs and liver transplantation 
(Schalm et al., 1997). 
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The main objective of this study was to diagnose and 
determine the prevalence of liver diseases through liver 
function enzyme tests (LFTs) in Islamabad, Pakistan.  
                                                        
MATERIALS AND METHODS 
The study was conducted in patients visiting Outdoor 
Patients Department (OPD) of Kahuta Research Laboratory 
(KRL) Islamabad for period of five months from September 
2012 to January 2013. A total of 250 patients were screened 
for the presence of liver disorders. A survey was conducted 
to access the prevalence of liver disorders through liver 
function enzyme tests (LFTs) viz., alanine aminotransferase 
(ALT), T. bilirubin, and alkaline phosphatase (ALP) and other 
information about sex, age, occupation, locality, personal 
history and socioeconomic status were collected on 
prescribed questionnaire. Blood samples were collected in 5 
ml EDTA coating vacutainers with the help of hypodermic 
syringe. Blood samples were centrifuged at 3000 rpm for 15 
minutes to collect the serum and then serum was stored at 
4°C for biochemical analysis. Biochemical tests for ALT, ALP 
and Bilirubin determination were performed following 
procedures used by Muhammad et al. (2013). The data was 
arranged in various groups and was analyzed through 
Correlation using SPSS version 16. 
 
RESULTS AND DISCUSSION 
During this study, a total of 250 blood samples 
consisting of 123 (49.2%) males and 127 (50.8%) females 
attending Kahuta Research Laboratory (KRL) Islamabad 
were screened for the presence of liver disorders. All the 
patients were found with general signs and symptoms 
related to liver abnormalities such as indigestion, fatigue, 
fever, weakness, loss of appetite, abdominal pain, dark urine 
and yellow eyes. 
Corelation coficient of ALT and T. Bilirubin 
The Alanine amino transaminase (ALT) showed a 
statistically significant positive correlation (r=0.33, p<0.01) 
with T. bilirubin shown in (Table 1). These results are similar 
to Loannou et al. (2006), who showed that the level of 
Alanine amino transaminase (ALT) and T. Bilirubin in hepatic 
tissues abruptly rise especially when liver tissues are 
damaged due to HCV.  
Corelation coficient of ALP and T. Bilirubin 
The Alkaline phosphatase (ALP) also showed a 
statistically positive correlation (r=0.219; p<0.01) with T. 
bilirubin (Table 1). Level of Alkaline phosphatase (ALP) in 
relation with T. Bilirubin becomes higher during bile duct 
obstruction and intra-hepatic cholestasis (Schafer and 
Sorrell, 1997). 
Corelation coficient of ALT and ALP 
In present study, Alanine transaminase (ALT) showed a 
statistically significant positive correlation with Alkaline 
phosphatase (ALP) (r=0.475; P<0.01) shown in (Table 1). 
Similar results were reported by previous studies. The level 
of ALT with respect to ALP has become a well-known 
marker in inflammatory necrosis in patients with chronic liver 
failure (Tarao et al., 2002). ALT level in relation with ALP 
level estimation considered as the most important test for 
recognition of acute and chronic hepatic injuries and thus 
meet clinical monitoring patient with chronic hepatic injuries 
(Dufour et al., 2001). 
 
Table 1. Correlation coefficient of total bilirubin, ALT and 
ALP among patients having liver diseases visiting KRL 
Hospital, Islamabad. ALT, ALP and Billirubin were 
expressed in U/L units. 
Corelation Cofficient r-Value p-Value 
Corelation coficient of ALT and T. Bil r=0.33 p<0.01 
Corelation coficient of ALP and T. Bil r=0.219 p<0.01 
Corelation coficient of ALT and ALP r=0.475 p<0.01 
 
Elevated level of LF-Enzymes with respect to age 
It has been observed that the level of ALT and ALP 
abruptly decreases in (1-15 years), and then it gradually 
increases in age groups (16-30 years), (31-45 years). Their 
level is much higher in (46-60 years). However the level of T. 
Bilirubin is higher in Children and adults in age groups (1-15 
years) and (46-60 years) but its level is slightly elevated in 
age groups (16-30 years) and (31-45 years) (Figure 1). 
 
 
Figure 1. Level of ALT, T. Bil and ALP among different 
age groups of patients visiting KRL Hospital, Islamabad. 
 
Previous studies have also shown similar results. 
Findings of Amarapukar (2000) showed that progression to 
cirrhosis is faster in those who acquired infections after the 
age of 35 years. Muhammad et al. (2013) found that HCV 
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was more prevalent in women (60.4%) than in men (39.6%), 
with the highest incidence (28%) in age group 24-34 years. 
Similar results are also highlighted by Lucidarme et al., 
(1998) who had reported that the progression to 
Hepatocellular carcinoma (HCC) is slower in patients before 
30 years of age as compare to older age. Ali et al. (2014) 
documented age, sex, diet, alcohol, and infection with 
hepatitis B virus (HBV) and/or hepatitis C virus (HCV) as the 
risk factors linked with HCC. It was found that point mutation 
at MDM2-SNP309 gene from T to G may be responsible for 
HCC in patients with HCV. 
 
CONCLUSION AND SUGGESTIONS 
It is concluded that elevation of liver enzymes is 
responsible for liver disorders. It is recommended to avoid 
those medications which cause liver inflammation 
responsible for excess release of liver enzymes. 
Epidemiological studies should be conducted occasionally to 
check the incidence rate of such chronic and disabling 
diseases.  
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